PDZ domain-phosphoinositide interactions in cell-signaling.
Zimmermann P
PDZ domain-phosphoinositide interactions in cell-signaling.
Live
The Marseille Cancer Research Center celebrates its 50th anniversary ! -
Gene expression profiling and clinical outcome in breast cancer.
Bertucci F, Finetti P, Cervera N, Maraninchi D, Viens P, Birnbaum D
The ErbB2 signaling network as a target for breast cancer therapy.
Badache A, Gonçalves A
Interaction of the stress protein p8 with Jab1 is required for Jab1-dependent p27 nuclear-to-cytoplasm translocation.
Malicet C, Hoffmeister A, Moreno S, Closa D, Dagorn JC, Vasseur S, Iovanna JL
Travel informations on the Tec kinases during lymphocyte activation.
Garçon F, Nunès JA
A combinatorial approach to create artificial homing endonucleases cleaving chosen sequences.
Smith J, Grizot S, Arnould S, Duclert A, Epinat JC, Chames P, Prieto J, Redondo P, Blanco FJ, Bravo J, Montoya G, Pâques F, Duchateau P
Structural basis of syndecan-4 phosphorylation as a molecular switch to regulate signaling.
Koo BK, Jung YS, Shin J, Han I, Mortier E, Zimmermann P, Whiteford JR, Couchman JR, Oh ES, Lee W
Synthesis and antiviral evaluation of cyclic and acyclic 2-methyl-3-hydroxy-4-pyridinone nucleoside derivatives.
Barral K, Balzarini J, Neyts J, De Clercq E, Hider RC, Camplo M
Engineering of large numbers of highly specific homing endonucleases that induce recombination on novel DNA targets.
Arnould S, Chames P, Perez C, Lacroix E, Duclert A, Epinat JC, Stricher F, Petit AS, Patin A, Guillier S, Rolland S, Prieto J, Blanco FJ, Bravo J, Montoya G, Serrano L, Duchateau P, Pâques F
Inactivation of Ku-mediated end joining suppresses mec1Delta lethality by depleting the ribonucleotide reductase inhibitor Sml1 through a pathway controlled by Tel1 kinase and the Mre11 complex.
Corda Y, Lee SE, Guillot S, Walther A, Sollier J, Arbel-Eden A, Haber JE, Géli V